Platelets and their role in cancer evolution and immune system

Por Karachaliou, Niki, Pilotto, Sara, Bria, Emilio, Rosell, Rafael
Publicado no Transl Lung Cancer Res (2015)

MET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapy

Por Pilotto, Sara, Gkountakos, Anastasios, Carbognin, Luisa, Scarpa, Aldo, Tortora, Giampaolo, Bria, Emilio
Publicado no Ann Transl Med (2017)

Cellular and molecular biology of small cell lung cancer: an overview

Por Karachaliou, Niki, Pilotto, Sara, Lazzari, Chiara, Bria, Emilio, de Marinis, Filippo, Rosell, Rafael
Publicado no Transl Lung Cancer Res (2016)

Targeting targeted agents: open issues for clinical trial design

Por Giannarelli Diana, Cuppone Federica, Carlini Paolo, Di Maio Massimo, Bria Emilio, Cognetti Francesco, Milella Michele
Publicado em 2009-05-01

Targeting targeted agents: open issues for clinical trial design

Por Bria, Emilio, Di Maio, Massimo, Carlini, Paolo, Cuppone, Federica, Giannarelli, Diana, Cognetti, Francesco, Milella, Michele
Publicado em 2009

Tackling ALK in non-small cell lung cancer: the role of novel inhibitors

Por Facchinetti, Francesco, Tiseo, Marcello, Di Maio, Massimo, Graziano, Paolo, Bria, Emilio, Rossi, Giulio, Novello, Silvia
Publicado no Transl Lung Cancer Res (2016)

Deciphering Crosstalk Circuits in Non-small Cell Lung Cancers with an Increasing Interval Length of Low Dose CT Screening

Por Rosell, Rafael, Karachaliou, Niki, Chaib, Imane, Pilotto, Sara, Bria, Emilio, Fernández-Martínez, Juan Luis, Ramirez, Jose Luis
Publicado no EBioMedicine (2015)

Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research

Por Bonomi, Maria, Pilotto, Sara, Milella, Michele, Massari, Francesco, Cingarlini, Sara, Brunelli, Matteo, Chilosi, Marco, Tortora, Giampaolo, Bria, Emilio
Publicado em 2011

CXC and CC Chemokines as Angiogenic Modulators in Nonhaematological Tumors

Por Santoni, Matteo, Bracarda, Sergio, Nabissi, Massimo, Massari, Francesco, Conti, Alessandro, Bria, Emilio, Tortora, Giampaolo, Santoni, Giorgio, Cascinu, Stefano
Publicado em 2014

Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancer

Por Pilotto, Sara, Carbognin, Luisa, Karachaliou, Niki, Garassino, Marina, Cuppone, Federica, Petraglia, Sandra, Rosell, Rafael, Tortora, Giampaolo, Bria, Emilio
Publicado no Transl Lung Cancer Res (2015)

Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Ne...

Por Carbognin, Luisa, Pilotto, Sara, Nortilli, Rolando, Brunelli, Matteo, Nottegar, Alessia, Sperduti, Isabella, Giannarelli, Diana, Bria, Emilio, Tortora, Giampaolo
Publicado no Oncologist (2016)

First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer

Por Vaccaro, Vanja, Bria, Emilio, Sperduti, Isabella, Gelibter, Alain, Moscetti, Luca, Mansueto, Giovanni, Ruggeri, Enzo Maria, Gamucci, Teresa, Cognetti, Francesco, Milella, Michele
Publicado em 2013

Integrating the molecular background of targeted therapy and immunotherapy in lung cancer: a way to explore the impact of mutational landscape on tumor immunogenicity

Por Pilotto, Sara, Molina-Vila, Miguel Angel, Karachaliou, Niki, Carbognin, Luisa, Viteri, Santiago, González-Cao, Maria, Bria, Emilio, Tortora, Giampaolo, Rosell, Rafael
Publicado no Transl Lung Cancer Res (2015)

Maintenance therapy in NSCLC: why? To whom? Which agent?

Por Maione Paolo, Garassino Marina, Di Maio Massimo, Cortinovis Diego, Banna Giuseppe, Tiseo Marcello, Milella Michele, Novello Silvia, Martelli Olga, Vavalà Tiziana, Bria Emilio
Publicado em 2011-05-01

Maintenance therapy in NSCLC: why? To whom? Which agent?

Por Novello, Silvia, Milella, Michele, Tiseo, Marcello, Banna, Giuseppe, Cortinovis, Diego, Di Maio, Massimo, Garassino, Marina, Maione, Paolo, Martelli, Olga, Vavalà, Tiziana, Bria, Emilio
Publicado em 2011

Metastatic pancreatic cancer: Is there a light at the end of the tunnel?

Por Vaccaro, Vanja, Sperduti, Isabella, Vari, Sabrina, Bria, Emilio, Melisi, Davide, Garufi, Carlo, Nuzzo, Carmen, Scarpa, Aldo, Tortora, Giampaolo, Cognetti, Francesco, Reni, Michele, Milella, Michele
Publicado no World J Gastroenterol (2015)

Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder

Por Massari, Francesco, Bria, Emilio, Ciccarese, Chiara, Munari, Enrico, Modena, Alessandra, Zambonin, Valentina, Sperduti, Isabella, Artibani, Walter, Cheng, Liang, Martignoni, Guido, Tortora, Giampaolo, Brunelli, Matteo
Publicado no PLoS One (2015)

Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials

Por Loupakis, Fotios, Bria, Emilio, Vaccaro, Vanja, Cuppone, Federica, Milella, Michele, Carlini, Paolo, Cremolini, Chiara, Salvatore, Lisa, Falcone, Alfredo, Muti, Paola, Sperduti, Isabella, Giannarelli, Diana, Cognetti, Francesco
Publicado em 2010

Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma,...

Por Carbognin, Luisa, Pilotto, Sara, Milella, Michele, Vaccaro, Vanja, Brunelli, Matteo, Caliò, Anna, Cuppone, Federica, Sperduti, Isabella, Giannarelli, Diana, Chilosi, Marco, Bronte, Vincenzo, Scarpa, Aldo, Bria, Emilio, Tortora, Giampaolo
Publicado no PLoS One (2015)

Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: Meta-analysis of randomized trials

Por Cuppone, Federica, Bria, Emilio, Giannarelli, Diana, Vaccaro, Vanja, Milella, Michele, Nisticò, Cecilia, Ruggeri, Enzo Maria, Sperduti, Isabella, Bracarda, Sergio, Pinnarò, Paola, Lanzetta, Gaetano, Muti, Paola, Cognetti, Francesco, Carlini, Paolo
Publicado em 2010